Biomarker testing of cytology specimens in personalized medicine for lung cancer patients
Every patient with advanced non-small cell lung cancer (NSCLC) should be tested for targetable driver mutations and gene arrangements that may open avenues for targeted therapy. As most patients with NSCLC in the advanced stage of the disease are not candidates for surgery, these tests have to be pe...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Книга |
| Опубліковано: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2022-11-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Примірник 1 | Доступно |